コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 women, 161 (46%) had either a unicuspid or a bicuspid aortic valve.
2 ying aortic valve abnormalities as seen with bicuspid aortic valve.
3 center, 245 patients were identified to have bicuspid aortic valve.
4 on are common complications in patients with bicuspid aortic valve.
5 cardiovascular specialist after diagnosis of bicuspid aortic valve.
6 lterations from 4D flow MRI in patients with bicuspid aortic valve.
7 ing may improve clinical outcomes of TAVR in bicuspid aortic valve.
8 eneration Evolut R/PRO or Sapien 3 valves in bicuspid aortic valve.
9 ociated cardiac malformation that included a bicuspid aortic valve.
10 ne had truncus arteriosus, and another had a bicuspid aortic valve.
11 yzed by microscopy to identify tricuspid and bicuspid aortic valves.
12 stify surgical intervention in patients with bicuspid aortic valves.
13 ysms (maximal diameter > 4.0 cm), and 10 had bicuspid aortic valves.
14 ng aorta with ventricular septal defect, and bicuspid aortic valves.
15 the development of atrial septal defects and bicuspid aortic valves.
16 ith Loeys-Dietz syndrome, 2 women (10%) with bicuspid aortic valves, 2 women (10%) with a family hist
17 ); partially fused aortic valve, 12% (n=25); bicuspid aortic valve, 23% (n=47); and unicuspid aortic
19 randomized clinical trial, 220 patients with bicuspid aortic valve (43 women; 46+/-13 years of age) w
21 rison, outcomes of 13,205 adults (2,079 with bicuspid aortic valves, 73 with Marfan syndrome, and 11,
22 xcluding individuals with Marfan syndrome or bicuspid aortic valve, a family history of AD was associ
26 th Sapien 3 and Evolut R/PRO implantation in bicuspid aortic valve anatomy; a higher rate of moderate
27 -dominant aortic valve disease consisting of bicuspid aortic valve and aortic valve calcification was
29 n reducing the growth of aortic diameters in bicuspid aortic valve and if it slows the progression of
31 In the community, asymptomatic patients with bicuspid aortic valve and no or minimal hemodynamic abno
32 zygous Mib1 Cep192 Tmx3;Bcl7a mice developed bicuspid aortic valve and other valve-associated defects
33 ient-specific computer simulation of TAVR in bicuspid aortic valve and to determine whether patient-s
34 s imply higher energy losses associated with bicuspid aortic valves and dilated ascending aortic geom
35 e risk of aortic dissection in patients with bicuspid aortic valves and severe aortic enlargement: th
36 ar septal defects, patent ductus arteriosus, bicuspid aortic valve, and coarctation of the aorta as w
37 ts were more likely to have Marfan syndrome, bicuspid aortic valve, and prior aortic surgery (all, p
38 ch1, or RBPJ displayed enlarged valve cusps, bicuspid aortic valve, and septal defects, indicating th
41 isk factors for dissection: Marfan syndrome, bicuspid aortic valves, and larger aortic dimensions.
42 paroxysmal, persistent, or chronic AF, with bicuspid aortic valves, and patients who died within 48
43 n criteria were connective tissue disorders, bicuspid aortic valves, and survivors of a prior AAE.
44 Making the decision regarding the timing of bicuspid aortic valve aneurysm surgery even more difficu
50 tic hemodynamics, with separate networks for bicuspid aortic valve (BAV) (994 in the training set and
54 ic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) aortic stenosis (AS) versus
59 ar ejection fraction (LVEF) in patients with bicuspid aortic valve (BAV) disease has not been previou
62 Ascending aortic dilation is important in bicuspid aortic valve (BAV) disease, with increased risk
69 determine whether the morphologic subtype of bicuspid aortic valve (BAV) is associated with valve int
78 ittle is known about the association between bicuspid aortic valve (BAV) morphologic findings and the
79 increase in the proportion of patients with bicuspid aortic valve (BAV) morphology as the age of the
80 ltered ascending aorta (AAo) hemodynamics in bicuspid aortic valve (BAV) patients and its association
84 d to increased use of TAVR for patients with bicuspid aortic valve (BAV) stenosis despite the exclusi
87 y who also exhibited LVOT defects, including bicuspid aortic valve (BAV), coarctation of the aorta (C
88 evelops in most patients with a congenitally bicuspid aortic valve (BAV), in others with this anomaly
89 dies have established familial clustering of bicuspid aortic valve (BAV), presumably indicating genet
90 Dcbld2(-/-) mice have a high prevalence of bicuspid aortic valve (BAV), spontaneous aortic valve ca
92 randomized, controlled trials have excluded bicuspid aortic valve (BAV), which is the most frequent
98 tion in the ascending aorta in patients with bicuspid aortic valves (BAV) have influenced strategies
100 ic aortic aneurysms (ATAAs) in patients with bicuspid aortic valves (BAV) versus patients with tricus
104 idney and cardiovascular malformation (i.e., bicuspid aortic valve, bicuspid aortic valve with coarct
106 s, left ventricular noncompaction (LVNC) and bicuspid aortic valve, can be caused by a set of inherit
107 ith Marfan syndrome compared with those with bicuspid aortic valves confirm that operative management
109 fibrillation, and had a higher prevalence of bicuspid aortic valve, diabetes, and peripheral vascular
110 rtic disease, peripheral artery disease, and bicuspid aortic valve disease have been updated with new
111 rtic disease, peripheral artery disease, and bicuspid aortic valve disease have been updated with new
112 ng aortic aneurysm surgery in the setting of bicuspid aortic valve disease is complex, with multiple
113 oracic aortopathy after AVR in patients with bicuspid aortic valve disease is substantially different
114 aortic disease such as the Marfan syndrome, bicuspid aortic valve disease, and hereditary aortic ane
116 uses underdeveloped aortic root leading to a bicuspid aortic valve due to the absence of non-coronary
118 ndocardial genes whose inactivation leads to bicuspid aortic valve formation and calcific aortic valv
120 hymal transition, and NOTCH1 mutations cause bicuspid aortic valve; however, the temporal requirement
121 e heterozygous MIB1 missense allele leads to bicuspid aortic valve in a NOTCH-sensitized genetic back
122 lities, including Marfan's syndrome in four, bicuspid aortic valve in four, and aortitis in one.
123 co-segregating with tetralogy of Fallot and bicuspid aortic valve in maternal relatives (p.Tyr2819Te
124 shared genetic substrate underlying LVNC and bicuspid aortic valve in which MIB1-NOTCH variants plays
125 t to abnormalities (such as Marfan syndrome, bicuspid aortic valve, inflammatory vasculitis, atherosc
128 1,000 live births if the potentially serious bicuspid aortic valve is included), and of all forms inc
131 similar to the pattern seen in nonsyndromic bicuspid aortic valve, is equally prevalent (20-30%) in
132 addition, another 20/1,000 live births have bicuspid aortic valves, isolated anomalous lobar pulmona
133 ient-specific computer simulation of TAVR in bicuspid aortic valve may predict the development of imp
134 iseases, including calcific aortic stenosis, bicuspid aortic valves, mitral valve prolapse, and rheum
135 tricuspid aortic valves (n = 27), calcified bicuspid aortic valves (n = 23), and control tissue from
140 R, 1.11; 95% CI, 1.07-1.15), patients with a bicuspid aortic valve (OR, 1.09; 95% CI, 1.05-1.13), in-
141 85), ventricular septal defect (P=0.12), and bicuspid aortic valve (P=0.14) did not carry an increase
143 retrospective study was performed on TAVR in bicuspid aortic valve patients that had both pre- and po
145 survival both for tricuspid aortic valve and bicuspid aortic valve patients, with the latter being si
147 with age, and it is often associated with a bicuspid aortic valve present in 1-2% of the population.
149 m that operative management of patients with bicuspid aortic valves should not be extrapolated from M
150 placement in low-surgical risk patients with bicuspid aortic valve stenosis achieved favorable 30-day
152 replacement (TAVR) in low-risk patients with bicuspid aortic valve stenosis have not been studied in
154 s self-expandable valve for the treatment of bicuspid aortic valve stenosis) registry included 353 co
156 rates of Marfan syndrome and lower rates of bicuspid aortic valve than those undergoing bio-CVG or m
157 neurysmal progression in Npr2(+/-) mice with bicuspid aortic valves than those with tricuspid valves.
159 tic valve, partially fused aortic valve, and bicuspid aortic valve+unicuspid aortic valve, respective
160 ricle, aberrant semilunar valve development, bicuspid aortic valve, ventricular septal defects, and e
162 County, Minn (age, 32+/-20 years; 65% male), bicuspid aortic valve was diagnosed between 1980 and 199
167 ortic aneurysms variably associated with the bicuspid aortic valve was used for identification of add
169 rm and ectoderm caused glandular defects and bicuspid aortic valve, which indicates that the FGF8 end
170 r malformation (i.e., bicuspid aortic valve, bicuspid aortic valve with coarctation of the aorta, or
171 ve since expanded the eligible population to bicuspid aortic valve with feasible anatomy; small aorti
174 of mice heterozygous for Npr2 had congenital bicuspid aortic valves, with worse aortic valve function